Next Gen High Level Design of Facility Layout

Develop a Generation 2 solution in the form of a stand-alone facility layout, equipment list, project delivery methodology, high level cost estimate and implementation schedule.

Project status

68% Completed

Industry Need

Clarity on which technology and regulatory projects will deliver the vision for the future.

Solution

Conduct more detailed design and engineering to show value of NIIMBL projects.

Outputs/Deliverables

1st Gen Facility Design (done)
Equipment URS – 1Q2024
2nd Gen Facility Design – 2Q2024
List of projects that enable 2nd gen design – 3Q2024

Impacts

Detailed business case for integrated continuous bioprocessing (ICB) with capital cost estimates.

Line of sight from corporate manufacturing goals to NIIMBL projects.

Additional Project Information (Members Only)

Updates
Value Proposition
Related Publications
Deliverables

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Project Lead

NIIMBL

Participating Organizations

Amgen Inc.

AstraZeneca

Bristol-Myers Squibb

CSL Behring, LLC

Cytiva

Eli Lilly and Company

Genentech, Inc.

GlaxoSmithKline, LLC

IPS-Integrated Project Services, LLC

Janssen Research & Development, LLC

Merck Sharp & Dohme LLC

MilliporeSigma/EMD Serono

Pfizer, Inc.

Sanofi

Sartorius Stedim

Takeda Pharmaceuticals